News
GSK Falls
Digest more
The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...
Investing.com -- GSK (LON:GSK) shares dropped more than 6% on Friday after a U.S. Food and Drug Administration advisory panel voted against the benefit-risk profile of Blenrep (belantamab ...
Drugmaker GSK said on Friday that the US Food and Drug Administration's Oncologic Drugs Advisory Committee had voted against ...
GSK PLC closed 16.45% short of its 52-week high of £16.79, which the company reached on September 9th.
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...
Explore more
Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...
London: GSK plc has received approval from the US Food and Drug Administration (FDA) for a prefilled syringe presentation of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results